Drugs that contain Deoxycholic Acid

1. List of Kybella drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8242294 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
May, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8846066 KYTHERA BIOPHARMS Methods and related compositions for reduction of fat and skin tightening
Feb, 2025

(2 years from now)

US8298556 KYTHERA BIOPHARMS Methods and related compositions for the non-surgical removal of fat
Aug, 2025

(2 years from now)

US7622130 KYTHERA BIOPHARMS Methods and compositions for the non-surgical removal of fat
Dec, 2027

(4 years from now)

US7754230 KYTHERA BIOPHARMS Methods and related compositions for reduction of fat
Dec, 2027

(4 years from now)

US8546367 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
Feb, 2028

(5 years from now)

US9949986 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
Feb, 2028

(5 years from now)

US9636349 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
Feb, 2028

(5 years from now)

US9522155 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
Feb, 2028

(5 years from now)

US8461140 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
Feb, 2028

(5 years from now)

US8883770 KYTHERA BIOPHARMS Synthetic bile acid compositions and methods
Feb, 2028

(5 years from now)

US8653058 KYTHERA BIOPHARMS Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
Mar, 2030

(7 years from now)

US8101593 KYTHERA BIOPHARMS Formulations of deoxycholic acid and salts thereof
Mar, 2030

(7 years from now)

US8367649 KYTHERA BIOPHARMS Formulations of deoxycholic acid and salts thereof
Mar, 2030

(7 years from now)

US10500214 KYTHERA BIOPHARMS Formulations of deoxycholic acid and salts thereof
Mar, 2030

(7 years from now)

Market Authorisation Date: 29 April, 2015

Treatment: Method for reduction of submental fat; Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as described in the approved labeling

Dosage: SOLUTION;SUBCUTANEOUS

How can I launch a generic of KYBELLA before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic